Nucleai Secures $14M to Advance Spatial AI Technology in Biomarker Discovery

Nucleai is at the forefront of combining technology and healthcare through its innovative spatial AI biomarker platform.

Source: Nucleai

Company Name: Nucleai
Location: Chicago, IL, and Tel Aviv, Israel
Sector: Spatial AI Biomarker
Funding Details: Raised $14M, led by M Ventures, with support from existing investors.
Purpose of Investment: To accelerate the deployment of spatial analysis technology.
Leadership: Led by CEO Avi Veidman.

Product: An AI-powered spatial biomarker platform that uses military intelligence-grade geospatial analytical methods to analyze cellular conversations and interactions within tissue samples, providing actionable insights for pathologists and researchers.

About Company: Nucleai is at the forefront of combining technology and healthcare through its innovative spatial AI biomarker platform. By interpreting complex cellular data within tissue samples, it aids in the development of advanced treatments like bi-specifics, ADCs, and immunotherapy.

Pelotero Secures $3M in Seed Funding for AI-Powered Player Intelligence Platform

Pelotero is pioneering the integration of AI with sports coaching to create personalized training experiences.

Brenig Therapeutics Secures $65M in Series A Funding for Neurology Drug Development

Brenig Therapeutics is a neurology-focused drug development company utilizing an AI/ML-based discovery platform,

Monarch Tractor Secures $133M in Series C Funding for AI-Driven Agricultural Expansion

Monarch Tractor is pioneering the transformation of the agricultural industry by integrating AI and autonomous technology into its electric vehicle solutions, thus enhancing farm management and sustainability practices globally.

Read next